돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 2182924생성일: 2026년 10월 25일

1,1'-Carbonyldiimidazole → (3R)-6-cyclohexyl-N-hydroxy-3-(3-methyl-1,2,4-oxadiazol-5-yl)hexanamide

https://huagongshe.com/reaction/2182924

반응식

참여 물질

역할이름HCID투입량
반응물1,1'-CarbonyldiimidazoleHCID 68263—
반응물Hydroxyamine hydrochlorideHCID 443297—
반응물(3R)-6-cyclohexyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)hexanoic acidHCID 59909792—
용매TetrahydrofuranHCID 8028—
생성물(3R)-6-cyclohexyl-N-hydroxy-3-(3-methyl-1,2,4-oxadiazol-5-yl)hexanamideHCID 994401145.5%

반응 단계

A solution of (3R)-6-cyclohexyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)hexanoic acid (Preparation 45) (170 mg, 0.61 mmol) in anhydrous tetrahydrofuran (2 ml) was treated with 1,1′-carbonyldiimidazole (98 mg, 0.61 mmol) and the mixture stirred at room temperature under a nitrogen atmosphere for 20 minutes. Hydroxylamine hydrochloride (42 mg, 0.61 mmol) was then added and the mixture stirred for 18 hours. The solvent was removed under reduced pressure and the residue partitioned between hydrochloric acid (0.5M) and ethyl acetate. The layers were separated and the organic phase was washed with water, dried over anhydrous sodium sulphate, filtered and solvent removed under reduced pressure. The residue was purified by column chromatography on silica gel eluting with dichloromethane:methanol (98:2) to afford the title compound as an oil (82 mg).

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US06897306B2
출처 데이터셋uspto-grants-2005_05
ORD IDord-fb0c402a95cf4048bc7d651d3bdc344e
출처 메모uspto-grants-2005_05